Cargando…

Construction of a ferroptosis-related five-lncRNA signature for predicting prognosis and immune response in thyroid carcinoma

BACKGROUND: Thyroid carcinoma (THCA) is the most common endocrine-related malignant tumor. Despite the good prognosis, some THCA patients may deteriorate into more aggressive diseases, leading to poor survival. This may be alleviated by developing a novel model to predict the risk of THCA, including...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qin, Yuan, Zhang, Dai, Zhang, Huan, Hou, Lan, Wang, Zhe, Yang, Liu, Zhang, Mingkun, Zhao, Ge, Yao, Qing, Ling, Rui, Zhang, Juliang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520852/ https://www.ncbi.nlm.nih.gov/pubmed/36175889 http://dx.doi.org/10.1186/s12935-022-02674-z

Ejemplares similares

Prognostic value of a five-lncRNA signature in esophageal squamous cell carcinoma
por: zhang, Lan, et al.
Publicado: (2020)

Ferroptosis-related gene signature predicts the prognosis of papillary thyroid carcinoma
por: Shi, Jinyuan, et al.
Publicado: (2021)

Characterization of a ferroptosis and iron-metabolism related lncRNA signature in lung adenocarcinoma
por: Yao, Jie, et al.
Publicado: (2021)

Identification and potential mechanisms of a 4-lncRNA signature that predicts prognosis in patients with laryngeal cancer
por: Zhang, Guihai, et al.
Publicado: (2019)

An immune-related lncRNA signature predicts prognosis and adjuvant chemotherapeutic response in patients with small-cell lung cancer
por: Zhang, Zhihui, et al.
Publicado: (2021)

Development and validation of ferroptosis-related lncRNAs prognosis signatures in kidney renal clear cell carcinoma
por: Xing, Xiao-Liang, et al.
Publicado: (2021)

Construction and Validation of a Novel Ferroptosis-Related lncRNA Signature to Predict Prognosis in Colorectal Cancer Patients
por: Zhang, Wenqi, et al.
Publicado: (2021)

Identification of a ferroptosis-related lncRNA signature with prognosis for Wilms tumor
por: Liu, Hengchen, et al.
Publicado: (2021)

A novel qualitative signature based on lncRNA pairs for prognosis prediction in hepatocellular carcinoma
por: Bu, Xiaoyun, et al.
Publicado: (2022)

Construction and Validation of a Ferroptosis-Related lncRNA Signature as a Novel Biomarker for Prognosis, Immunotherapy and Targeted Therapy in Hepatocellular Carcinoma
por: Zhang, Ze, et al.
Publicado: (2022)

A five lncRNA signature for prognosis prediction in hepatocellular carcinoma
por: Sun, Yongqiang, et al.
Publicado: (2019)

An Immune Gene-Related Five-lncRNA Signature for to Predict Glioma Prognosis
por: Wang, Xinzhuang, et al.
Publicado: (2020)

A novel signature constructed by ferroptosis-associated genes (FAGs) for the prediction of prognosis in bladder urothelial carcinoma (BLCA) and associated with immune infiltration
por: Luan, Jiao-chen, et al.
Publicado: (2021)

A ferroptosis-related lncRNA signature predicts prognosis in ovarian cancer patients
por: Peng, Jing, et al.
Publicado: (2021)

Ferroptosis-related lncRNA signature predicts the prognosis and immune microenvironment of hepatocellular carcinoma
por: Fang, Chongkai, et al.
Publicado: (2022)

Ferroptosis-related lncRNA signature predicts prognosis and immunotherapy efficacy in cutaneous melanoma
por: Xu, Yujian, et al.
Publicado: (2022)

Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma
por: Xu, Zhijie, et al.
Publicado: (2021)

Construction of five cuproptosis-related lncRNA signature for predicting prognosis and immune activity in skin cutaneous melanoma
por: Yang, Xiaojing, et al.
Publicado: (2022)

A New Ferroptosis-Related lncRNA Signature Predicts the Prognosis of Bladder Cancer Patients
por: Chen, Mei, et al.
Publicado: (2021)

Functional polymorphisms in LncRNA HOTAIR contribute to susceptibility of pancreatic cancer
por: Jiang, Dawei, et al.
Publicado: (2019)

Construction and validation of a ferroptosis-related long noncoding RNA signature in clear cell renal cell carcinoma
por: Zhu, Zhenpeng, et al.
Publicado: (2022)

Constructing an immune‐ and ferroptosis‐related lncRNA signature to predict the immune landscape of human bladder cancer
por: Li, Xing, et al.
Publicado: (2022)

Identification of Five Ferroptosis-Related LncRNAs as Novel Prognosis and Diagnosis Signatures for Renal Cancer
por: Shu, Xiangjun, et al.
Publicado: (2022)

LncRNA PELATON, a Ferroptosis Suppressor and Prognositic Signature for GBM
por: Fu, Haijuan, et al.
Publicado: (2022)

Construction and validation of a cuproptosis-related five-lncRNA signature for predicting prognosis, immune response and drug sensitivity in breast cancer
por: Li, Chun, et al.
Publicado: (2023)

Comprehensive Analysis of a Ferroptosis-Related lncRNA Signature for Predicting Prognosis and Immune Landscape in Osteosarcoma
por: Zhang, Yiming, et al.
Publicado: (2022)

A novel ferroptosis-related lncRNA signature for prognosis prediction in gastric cancer
por: Wei, Jianming, et al.
Publicado: (2021)

Computational Identification of Immune- and Ferroptosis-Related LncRNA Signature for Prognosis of Hepatocellular Carcinoma
por: Huang, Anmin, et al.
Publicado: (2021)

Calculated identification of mutator-derived lncRNA signatures of genomic instability to predict the clinical outcome of muscle-invasive bladder cancer
por: Liang, Yingchun, et al.
Publicado: (2021)

A novel prognostic cancer-related lncRNA signature in papillary renal cell carcinoma
por: Chen, Binghai, et al.
Publicado: (2021)

A potential prognostic prediction model of colon adenocarcinoma with recurrence based on prognostic lncRNA signatures
por: Jin, Lipeng, et al.
Publicado: (2020)

A Ferroptosis-Related LncRNA Signature Associated with Prognosis, Tumor Immune Environment, and Genome Instability in Hepatocellular Carcinoma
por: Lian, Jie, et al.
Publicado: (2022)

Construction and validation of a histone acetylation-related lncRNA prognosis signature for ovarian cancer
por: Hu, Xiao-Qian, et al.
Publicado: (2022)

Constructe a novel 5 hypoxia genes signature for cervical cancer
por: Yang, Yang, et al.
Publicado: (2021)

Machine learning-based construction of a ferroptosis and necroptosis associated lncRNA signature for predicting prognosis and immunotherapy response in hepatocellular cancer
por: Zhao, Lei, et al.
Publicado: (2023)

Construction and validation of a glycolysis-related lncRNA signature for prognosis prediction in Stomach Adenocarcinoma
por: Liao, Tianyou, et al.
Publicado: (2022)

Immune-related lncRNA classification of head and neck squamous cell carcinoma
por: Cao, Ruoyan, et al.
Publicado: (2022)

Ferroptosis-Related lncRNA Signature Correlates with the Prognosis, Tumor Microenvironment, and Therapeutic Sensitivity of Esophageal Squamous Cell Carcinoma
por: Zhu, Jiahao, et al.
Publicado: (2022)

Joint analysis of lncRNA m(6)A methylome and lncRNA/mRNA expression profiles in gastric cancer
por: Lv, Zhi, et al.
Publicado: (2020)

The construction of a novel ferroptosis-related lncRNA model to predict prognosis in colorectal cancer patients
por: Chen, Weihong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2cgdfo7nnl0pero9iqlk4h3o4g